China National Medicines Corporation Ltd.

SHSE:600511 Stock Report

Market Cap: CN¥25.9b

China National Medicines Balance Sheet Health

Financial Health criteria checks 6/6

China National Medicines has a total shareholder equity of CN¥18.5B and total debt of CN¥284.3M, which brings its debt-to-equity ratio to 1.5%. Its total assets and total liabilities are CN¥34.3B and CN¥15.9B respectively. China National Medicines's EBIT is CN¥2.3B making its interest coverage ratio -4.1. It has cash and short-term investments of CN¥8.3B.

Key information

1.5%

Debt to equity ratio

CN¥284.32m

Debt

Interest coverage ratio-4.1x
CashCN¥8.30b
EquityCN¥18.46b
Total liabilitiesCN¥15.88b
Total assetsCN¥34.34b

Recent financial health updates

Recent updates

We Think China National Medicines (SHSE:600511) Can Manage Its Debt With Ease

Nov 12
We Think China National Medicines (SHSE:600511) Can Manage Its Debt With Ease

The China National Medicines Corporation Ltd. (SHSE:600511) Third-Quarter Results Are Out And Analysts Have Published New Forecasts

Oct 25
The China National Medicines Corporation Ltd. (SHSE:600511) Third-Quarter Results Are Out And Analysts Have Published New Forecasts

China National Medicines Corporation Ltd.'s (SHSE:600511) Prospects Need A Boost To Lift Shares

Sep 26
China National Medicines Corporation Ltd.'s (SHSE:600511) Prospects Need A Boost To Lift Shares

Calculating The Fair Value Of China National Medicines Corporation Ltd. (SHSE:600511)

Sep 10
Calculating The Fair Value Of China National Medicines Corporation Ltd. (SHSE:600511)

Returns On Capital At China National Medicines (SHSE:600511) Paint A Concerning Picture

Jul 28
Returns On Capital At China National Medicines (SHSE:600511) Paint A Concerning Picture

China National Medicines Corporation Ltd.'s (SHSE:600511) Low P/E No Reason For Excitement

Jun 24
China National Medicines Corporation Ltd.'s (SHSE:600511) Low P/E No Reason For Excitement

China National Medicines (SHSE:600511) Has Announced That It Will Be Increasing Its Dividend To CN¥0.854

Jun 07
China National Medicines (SHSE:600511) Has Announced That It Will Be Increasing Its Dividend To CN¥0.854

Is China National Medicines (SHSE:600511) Using Too Much Debt?

Jun 05
Is China National Medicines (SHSE:600511) Using Too Much Debt?

Calculating The Fair Value Of China National Medicines Corporation Ltd. (SHSE:600511)

May 21
Calculating The Fair Value Of China National Medicines Corporation Ltd. (SHSE:600511)

Capital Allocation Trends At China National Medicines (SHSE:600511) Aren't Ideal

Apr 10
Capital Allocation Trends At China National Medicines (SHSE:600511) Aren't Ideal

China National Medicines (SHSE:600511) Could Easily Take On More Debt

Feb 28
China National Medicines (SHSE:600511) Could Easily Take On More Debt

Financial Position Analysis

Short Term Liabilities: 600511's short term assets (CN¥29.8B) exceed its short term liabilities (CN¥14.6B).

Long Term Liabilities: 600511's short term assets (CN¥29.8B) exceed its long term liabilities (CN¥1.3B).


Debt to Equity History and Analysis

Debt Level: 600511 has more cash than its total debt.

Reducing Debt: 600511's debt to equity ratio has reduced from 4.2% to 1.5% over the past 5 years.

Debt Coverage: 600511's debt is well covered by operating cash flow (593.5%).

Interest Coverage: 600511 earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies